DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $914,249 | +3.3% | 3,685 | -0.1% | 0.14% | +13.4% |
| Q2 2023 | $885,360 | -5.6% | 3,689 | -0.8% | 0.12% | -3.3% |
| Q1 2023 | $937,589 | +91.8% | 3,720 | +102.0% | 0.12% | +70.8% |
| Q4 2022 | $488,904 | -21.0% | 1,842 | -23.1% | 0.07% | -33.3% |
| Q3 2022 | $619,000 | +2.3% | 2,395 | +0.3% | 0.11% | +3.8% |
| Q2 2022 | $605,000 | -13.7% | 2,387 | -0.1% | 0.10% | +3.0% |
| Q1 2022 | $701,000 | -17.1% | 2,389 | -7.0% | 0.10% | -9.0% |
| Q4 2021 | $846,000 | -21.6% | 2,570 | -27.5% | 0.11% | -25.0% |
| Q3 2021 | $1,079,000 | +37.6% | 3,544 | +21.4% | 0.15% | +37.0% |
| Q2 2021 | $784,000 | +19.9% | 2,920 | +0.5% | 0.11% | +11.3% |
| Q1 2021 | $654,000 | -5.2% | 2,906 | -6.4% | 0.10% | -9.3% |
| Q4 2020 | $690,000 | +5.8% | 3,106 | +2.5% | 0.11% | +5.9% |
| Q3 2020 | $652,000 | -11.7% | 3,029 | -27.4% | 0.10% | 0.0% |
| Q2 2020 | $738,000 | +25.1% | 4,171 | -2.1% | 0.10% | +6.3% |
| Q1 2020 | $590,000 | -9.8% | 4,261 | 0.0% | 0.10% | +33.8% |
| Q4 2019 | $654,000 | +6.3% | 4,261 | 0.0% | 0.07% | -1.4% |
| Q3 2019 | $615,000 | -3.8% | 4,261 | -4.7% | 0.07% | -12.2% |
| Q2 2019 | $639,000 | +8.3% | 4,471 | 0.0% | 0.08% | +9.3% |
| Q1 2019 | $590,000 | +107.0% | 4,471 | +54.9% | 0.08% | +74.4% |
| Q4 2018 | $285,000 | -9.2% | 2,887 | 0.0% | 0.04% | -4.4% |
| Q3 2018 | $314,000 | +10.2% | 2,887 | 0.0% | 0.04% | +4.7% |
| Q2 2018 | $285,000 | +0.7% | 2,887 | 0.0% | 0.04% | -4.4% |
| Q1 2018 | $283,000 | +5.6% | 2,887 | 0.0% | 0.04% | +12.5% |
| Q4 2017 | $268,000 | +8.1% | 2,887 | 0.0% | 0.04% | +5.3% |
| Q3 2017 | $248,000 | +1.6% | 2,887 | 0.0% | 0.04% | -2.6% |
| Q2 2017 | $244,000 | -1.2% | 2,887 | 0.0% | 0.04% | 0.0% |
| Q1 2017 | $247,000 | +9.8% | 2,887 | 0.0% | 0.04% | +14.7% |
| Q4 2016 | $225,000 | -0.4% | 2,887 | 0.0% | 0.03% | 0.0% |
| Q3 2016 | $226,000 | -22.6% | 2,887 | 0.0% | 0.03% | -19.0% |
| Q2 2016 | $292,000 | +6.6% | 2,887 | 0.0% | 0.04% | +10.5% |
| Q1 2016 | $274,000 | +2.2% | 2,887 | 0.0% | 0.04% | 0.0% |
| Q4 2015 | $268,000 | +38.1% | 2,887 | +26.7% | 0.04% | +15.2% |
| Q3 2015 | $194,000 | -0.5% | 2,278 | 0.0% | 0.03% | +6.5% |
| Q2 2015 | $195,000 | +1.0% | 2,278 | 0.0% | 0.03% | 0.0% |
| Q1 2015 | $193,000 | -20.9% | 2,278 | -19.9% | 0.03% | +3.3% |
| Q4 2014 | $244,000 | +13.0% | 2,843 | 0.0% | 0.03% | +3.4% |
| Q3 2014 | $216,000 | -3.6% | 2,843 | 0.0% | 0.03% | -3.3% |
| Q2 2014 | $224,000 | +0.9% | 2,843 | -3.8% | 0.03% | -16.7% |
| Q1 2014 | $222,000 | +1.4% | 2,955 | +3.9% | 0.04% | +5.9% |
| Q4 2013 | $219,000 | +11.2% | 2,843 | 0.0% | 0.03% | 0.0% |
| Q3 2013 | $197,000 | +5.9% | 2,843 | -3.1% | 0.03% | -2.9% |
| Q2 2013 | $186,000 | – | 2,933 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |